Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 April 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Effect of race on extent of Crohn's disease

Crohn's disease is not more severe among black patients, who had an earlier age of diagnosis, and white females were more likely to present with obstructive symptoms compared with black females, reports July's issue of Diseases of the Colon & Rectum.

News image

fiogf49gjkf04

Common belief based on clinical experience suggests that Crohn's disease is more severe among black patients.

Little data exists on the effect of race on Crohn's disease.

Dr Peter Deveaux and colleagues compared multiple variables among black patients with Crohn's disease requiring surgery.

The variables in this patient group were compared to those of white patients presenting to a university colorectal surgery unit during a 5-year period.

65% of black females presented with inflammatory symptoms compared with 28% of white females
Diseases of the Colon & Rectum

The team reported that a total of 345 patients required surgery for Crohn's disease between 1998 and 2003.

The research team abstracted data from patient charts and prospectively maintained a database.

The abstracted data from the patient charts included age at diagnosis, age at first Crohn's disease surgery and presenting symptoms.

Other data abstracted by the team included incidence, number and location of fistulas at presentation, and number of Crohn's disease operations.

The researchers also obtained data on family history of inflammatory bowel disease, and data regarding medical insurance coverage.

The team reported that complete data were evaluable on 178 patients.

Patient variables were analyzed using the chi-squared, Fisher exact, and Student t-tests.

The researchers noted that the mean age at diagnosis was 28 years for white males and 20 years for black males.

The mean age of diagnosis amongst white females was 30 years, and 28 years for black females.

The researchers found that 37% of white females presented with obstructive symptoms versus 12% of black females.

The research team observed that 65% of black females presented with inflammatory symptoms compared with 28% of white females.

Of females presenting with fistulas, 15% of black patients had a rectovaginal fistula compared with 5% of white patients.

The team observed that 17% of black males and 21% of white males had intra-abdominal fistulas.

However, the team note that none of these differences were statistically significant.

The incidence of fistulas at presentation, mean number of fistulas, total number of operations, and family history of inflammatory bowel disease also did not differ.

Dr Deveaux's team concludes, “Contrary to expectations, Crohn's disease does not seem to be more severe among black patients, who had an earlier age of diagnosis, although this was not statistically significant.”

“Overall, there was no difference in disease presentation.”

“White females were more likely to present with obstructive symptoms compared with black females, who more often presented with inflammatory symptoms.”

“Among patients with fistulas, the incidence of rectovaginal fistulas was higher in black females compared with white females, and white males were somewhat more likely to have intra-abdominal fistulas than black males.”

“Although there was no demonstrated difference in incidence and mean number of fistulas at presentation, the number of operations for Crohn's disease, or family history of inflammatory bowel disease among blacks and whites, there are differences in presenting symptoms among these populations.”

Dis Col Rectum 2005: 48(7): 1404-9
12 July 2005

Go to top of page Email this page Email this page to a colleague

 25 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
PPI and risk of stroke
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Sleep deprivation and NAFLD in the USA
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 20 April 2018 
Two annexin A11 epitopes targeted by IgG1 and IgG4 autoantibodies were shared between patients with IAC/AIP and IgG4 antibodies blocked binding of IgG1 antibodies to the shared annexin A11 epitopes
 20 April 2018 
Obesity and physical activity in diverticulosis
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 20 April 2018 
Worldwide H.pylori prevalence
 19 April 2018 
Fibrosis in patients with chronic hepatitis B
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA
 18 April 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 18 April 2018 
Hep C treatment for sustained virologic response
 18 April 2018 
Endoscopic necrosectomy reduces risk of death 
 17 April 2018 
Colorectal cancer screening and ethnic inequities
 17 April 2018 
Training programs should consider radiation education for advanced endoscopy fellows
 17 April 2018 
Aspirin and pancreatic cancer
 16 April 2018 
Surgery for colorectal polyps has increased 
 16 April 2018 
Advanced fibrosis can be ruled out in primary health care patients
 16 April 2018 
Antibiotic use and colorectal adenoma
 13 April 2018 
Colorectal cancer cell lines
 13 April 2018 
Infliximab and corticosteroid-free clinical remission in Crohn's
 13 April 2018 
Teduglutide for children with short bowel syndrome
 12 April 2018 
Prescriptions for opiate drugs amongst primary care patients with IBD
 12 April 2018 
Lower GI bleeding related to comorbidity
 12 April 2018 
non–Clostridium difficile bacterial infections in IBD
 11 April 2018 
Bile acid deficiency in IBS 
 11 April 2018 
Stem cell therapy for fistulas in Crohn's
 11 April 2018 
Physician perception of IBD trial results
 10 April 2018 
Overweight in childhood and type 2 diabetes
 10 April 2018 
immunoglobulin G associates with clinical features of IBD
 10 April 2018 
T-cells repertoires in celiac disease
 09 April 2018 
Biomarker tests for colorectal cancer screening
 09 April 2018 
Fecal transplantation in C. difficile infection and treatment outcome 
 09 April 2018 
No weigh-loss drug improved all cardiometabolic risk factors
 06 April 2018 
Colonoscopy and colorectal cancer mortality
 06 April 2018 
Eosinophilic esophagitis and health-related quality of life
 05 April 2018 
Laparoscopic Nissen fundoplication for GERD treatment
 05 April 2018 
Random biopsies for neoplasia in IBD
 04 April 2018 
Alpha‐1 antitrypsin deficiency and liver disease
 04 April 2018 
Adjuvant chemotherapy for advanced colon cancer
 29 March 2018 
Prevention of metachronous gastric cancer
 29 March 2018 
Acute lower GI bleeding
 28 March 2018 
Decision aid used by IBD patients
 28 March 2018 
Transition for young adults with IBD
 28 March 2018 
Amitriptyline in functional dyspepsia
 27 March 2018 
Emergency department utilization for IBD 
 27 March 2018 
Management of hemorrhoids in the USA
 27 March 2018 
Adult ulcerative colitis
 26 March 2018 
Biological therapy response in IBD 
 26 March 2018 
Obesity and diverticulosis
 26 March 2018 
Practice guidelines for chronic constipation
 23 March 2018 
Health-related quality of life in eosinophilic esophagitis
 23 March 2018 
Genetics and chronic liver disease
 23 March 2018 
Global prevalence of H.pylori

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us